Business Context and Reporting Period
This Form 8-K filing by Acadia Healthcare Company, Inc. covers events occurring between May 15, 2012, and May 21, 2012. The report details the company's entry into a material definitive agreement for a public offering of common stock.
Key Financial Metrics
- Offering Size: 8,250,000 shares initially offered, with an additional 1,237,500 shares purchased under the underwriters' option.
- Offering Price: $15.50 per share.
- Net Proceeds: Approximately $139 million received after deducting underwriting discounts, commissions, and estimated expenses.
- Use of Proceeds: Principally to fund acquisition strategy and for general corporate purposes.
- Other Metrics: The filing does not provide specific data on revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes
The primary material change is the completion of a significant equity financing event. The company successfully closed the sale of shares on May 21, 2012, following the full exercise of the underwriters' option to purchase additional shares on May 17, 2012. This transaction significantly increased the company's cash position to support its strategic growth plans.
Guidance, Outlook, and Risks
Management Commentary: Management intends to utilize the net proceeds primarily to fund its acquisition strategy. The offering was conducted pursuant to a registration statement declared effective by the SEC on May 15, 2012.
Risks and Contingencies: The Underwriting Agreement includes customary representations, warranties, and covenants. Acadia agreed to indemnify the underwriters against certain liabilities incurred in connection with the Offering. The filing does not disclose specific new operational risks or contingencies beyond the standard terms of the underwriting agreement.
Investor Verification Checklist
- Verify the final closing date of May 21, 2012, and the full exercise of the 1,237,500 share option.
- Confirm the exact net proceeds of approximately $139 million against the gross offering value.
- Review the attached press releases (Exhibits 99.1 and 99.2) for additional details on the pricing and closing announcements.
- Examine the full Underwriting Agreement (Exhibit 1.1 to the Registration Statement) for specific indemnification liabilities and covenants.